CPS Technologies (CPSH) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
29 Jan, 2026Executive summary
Achieved record Q2 2025 revenue of $8.1 million, up 61% year-over-year, driven by strong demand for core products and new technologies, including increased SBIR funding.
Returned to profitability with net income of $104,000 ($0.01 per share), compared to a net loss of $954,000 ($0.07 per share) in Q2 2024.
Gross profit margin improved to 17% in Q2 2025 from negative in Q2 2024, reflecting higher sales and better production yields.
Strong backlog and ongoing expansion of manufacturing capacity, including a third production shift added to meet demand.
Focused on margin expansion, operational efficiency, and innovation, with new development contracts and commercial traction for AlMax materials.
Financial highlights
Q2 2025 revenue reached $8.1 million, a 61% increase year-over-year, with gross profit of $1.34 million (17% margin).
Operating profit was $137,000, reversing a $1.3 million loss in Q2 2024.
Cash and cash equivalents at June 28, 2025 were $2.4 million, with inventory rising to $5.2 million to support higher demand.
No borrowings under the $3.0 million line of credit as of June 28, 2025.
SG&A expenses increased to $1.20 million in Q2 2025, mainly due to higher variable compensation and commissions.
Outlook and guidance
On track for the best revenue year ever, with strong demand and robust pipeline expected to continue for the remainder of 2025.
Management expects further gross margin expansion and increased profitability in the second half of 2025.
Average order visibility is four to six months, with ongoing customer demand.
Committed to further margin improvement through manufacturing efficiencies and modernization initiatives.
Management expects existing resources to fund operations for the remainder of 2025.
Latest events from CPS Technologies
- 2026 meeting seeks approval for directors, executive pay, share increase, and auditor ratification.CPSH
Proxy filing20 Mar 2026 - Annual meeting to vote on directors, executive pay, share increase, and auditor ratification.CPSH
Proxy Filing10 Mar 2026 - Record revenue, margin gains, and facility expansion drive strong growth outlook.CPSH
Q4 20253 Mar 2026 - Revenue and margins fell in Q2, but new contracts and product launches support future growth.CPSH
Q2 20242 Feb 2026 - Record revenue, margin gains, and a $9.5M raise drive expansion and strong growth outlook.CPSH
Q3 202529 Jan 2026 - Record Q1 2025 revenue and profitability, with strong growth and improved margins.CPSH
Q1 202529 Jan 2026 - Q3 revenue fell 32% to $4.2M, but new contracts and capacity boost outlook for 2025.CPSH
Q3 202429 Jan 2026 - Record revenue, $12M order, and new contracts drive growth and innovation outlook.CPSH
21st Virtual Investor Summit Microcap Event12 Jan 2026 - Sequential revenue growth and new contracts position the company for a stronger 2025.CPSH
Q4 202426 Dec 2025